FC
Forte Capital Portfolio holdings
AUM
$930M
This Quarter Return
+6.73%
1 Year Return
+24.08%
3 Year Return
+98.29%
5 Year Return
+137.93%
10 Year Return
+353.16%
AUM
$884M
AUM Growth
+$884M
(+6.7%)
Cap. Flow
+$10.8M
Cap. Flow
% of AUM
1.22%
Top 10 Holdings %
Top 10 Hldgs %
36.72%
Holding
243
New
12
Increased
78
Reduced
128
Closed
7
Top Buys
| 1 |
Novo Nordisk
NVO
|
$6.43M |
| 2 |
Celestica
CLS
|
$5.53M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$5.38M |
| 4 |
Booz Allen Hamilton
BAH
|
$3.72M |
| 5 |
Insight Enterprises
NSIT
|
$3.14M |
Top Sells
| 1 |
Nike
NKE
|
$5.22M |
| 2 |
West Pharmaceutical
WST
|
$3.75M |
| 3 |
Trade Desk
TTD
|
$2.25M |
| 4 |
iShares Russell Mid-Cap Value ETF
IWS
|
$2.22M |
| 5 |
iShares Morningstar Mid-Cap Growth ETF
IMCG
|
$2.07M |
Sector Composition
| 1 | Technology | 21.81% |
| 2 | Consumer Discretionary | 12.28% |
| 3 | Financials | 9.64% |
| 4 | Healthcare | 9.39% |
| 5 | Communication Services | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Microsoft
MSFT
$3.76T
| $9.58M | 1.08% |
22,261
-345
| -2% | -$148K |
|
27
IQVIA
IQV
$31.4B
| $9.39M | 1.06% |
39,639
-55
| -0.1% | -$13K |
|
28
CME Group
CME
$97.1B
| $9.09M | 1.03% |
41,194
+751
| +2% | +$166K |
|
29
Jacobs Solutions
J
$17.1B
| $8.96M | 1.01% |
68,414
-1,655
| -2% | -$2.02M |
|
30
lululemon athletica
LULU
$23.8B
| $7.91M | 0.9% |
29,165
-1,435
| -5% | -$389K |
|
|
31
Novo Nordisk
NVO
$252B
| $7.74M | 0.88% |
65,001
+54,028
| +492% | +$6.43M |
|
32
Diamondback Energy
FANG
$41.2B
| $7.48M | 0.85% |
43,413
-797
| -2% | -$137K |
|
33
Schwab Fundamental US Small Company Index ETF
FNDA
$8.82B
| $7.21M | 0.82% |
121,099
+2,872
| +2% | +$171K |
|
34
Brown & Brown
BRO
$31.4B
| $7.1M | 0.8% |
68,529
-435
| -0.6% | -$45.1K |
|
35
W.R. Berkley
WRB
$27.4B
| $6.75M | 0.76% |
118,943
+38,630
| +48% | -$86.6K |
|
36
JPMorgan Chase
JPM
$824B
| $6.72M | 0.76% |
31,893
-320
| -1% | -$67.5K |
|
37
Vanguard Total Stock Market ETF
VTI
$524B
| $6.68M | 0.76% |
23,582
-175
| -0.7% | -$49.6K |
|
|
38
Celestica
CLS
$24.4B
| $6.07M | 0.69% |
118,691
+108,233
| +1,035% | +$5.53M |
|
39
iShares Russell Mid-Cap Growth ETF
IWP
$20.3B
| $5.71M | 0.65% |
48,710
-3,257
| -6% | -$382K |
|
|
40
Vertex Pharmaceuticals
VRTX
$102B
| $5.67M | 0.64% |
12,201
+11,576
| +1,852% | +$5.38M |
|
|
41
iShares Morningstar Mid-Cap Growth ETF
IMCG
$2.87B
| $5.57M | 0.63% |
76,334
-28,399
| -27% | -$2.07M |
|
|
42
Booz Allen Hamilton
BAH
$13.2B
| $5M | 0.57% |
30,734
+22,841
| +289% | +$3.72M |
|
43
Molina Healthcare
MOH
$9.6B
| $4.85M | 0.55% |
14,070
-787
| -5% | -$271K |
|
44
Alphabet (Google) Class C
GOOG
$2.79T
| $4.69M | 0.53% |
28,065
| – | – |
|
45
Paychex
PAYX
$48.8B
| $4.53M | 0.51% |
33,737
-26
| -0.1% | -$3.49K |
|
46
Berkshire Hathaway Class B
BRK.B
$1.08T
| $4.23M | 0.48% |
9,185
+71
| +0.8% | +$32.7K |
|
47
iShares Core S&P 500 ETF
IVV
$660B
| $4.06M | 0.46% |
7,042
-1,032
| -13% | -$595K |
|
48
Vanguard Growth ETF
VUG
$185B
| $3.97M | 0.45% |
10,351
-2,251
| -18% | -$864K |
|
49
Johnson & Johnson
JNJ
$429B
| $3.88M | 0.44% |
23,917
-136
| -0.6% | -$22K |
|
|
50
iShares Russell Mid-Cap Value ETF
IWS
$13.9B
| $3.75M | 0.42% |
28,390
-16,751
| -37% | -$2.22M |
|